S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
S&P 500   2,749.98 (+3.41%)
DOW   23,433.57 (+3.44%)
QQQ   200.57 (+2.12%)
AAPL   266.07 (+2.56%)
FB   174.28 (+3.23%)
MSFT   165.13 (+1.00%)
GOOGL   1,207.00 (+2.07%)
AMZN   2,043.00 (+1.56%)
CGC   14.83 (+2.28%)
NVDA   266.95 (+3.06%)
BABA   195.98 (-1.02%)
MU   48.29 (+3.76%)
GE   7.30 (+3.84%)
TSLA   548.84 (+0.62%)
AMD   48.79 (+2.59%)
T   29.89 (-0.63%)
ACB   0.85 (+6.23%)
F   5.03 (+6.79%)
NFLX   371.12 (-0.31%)
BAC   23.45 (+5.92%)
GILD   74.99 (+0.43%)
DIS   101.07 (-0.17%)
PRI   97.51 (+10.73%)
Log in

NASDAQ:ACHNAchillion Pharmaceuticals SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
$6.76
0.00 (0.00 %)
(As of 01/28/2020)
Add
Compare
Today's Range
$6.76
Now: $6.76
$6.76
50-Day Range
$6.76
MA: $6.76
$6.76
52-Week Range
$2.06
Now: $6.76
$7.01
VolumeN/A
Average Volume8.44 million shs
Market Capitalization$946.72 million
P/E RatioN/A
Dividend YieldN/A
Beta1.59

SEC Filings

Achillion Pharmaceuticals (NASDAQ:ACHN) SEC Filings

DateFilerForm TypeView
02/14/2020
3:31 PM
Achillion Pharmaceuticals (Subject)
Pentwater Capital Management LP (Filed by)
Form SC 13G
02/07/2020
5:11 AM
Achillion Pharmaceuticals (Filer)
Form 15-12B
02/02/2020
11:15 PM
Achillion Pharmaceuticals (Filer)
Form EFFECT
02/02/2020
11:15 PM
Achillion Pharmaceuticals (Filer)
Form EFFECT
02/02/2020
11:15 PM
Achillion Pharmaceuticals (Filer)
Form EFFECT
02/02/2020
11:15 PM
Achillion Pharmaceuticals (Filer)
Form EFFECT
01/30/2020
4:15 PM
Achillion Pharmaceuticals (Issuer)
G1 EXECUTION SERVICES, LLC (Reporting)
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (Reporting)
SUSQUEHANNA SECURITIES, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2020
4:07 PM
Achillion Pharmaceuticals (Issuer)
G1 EXECUTION SERVICES, LLC (Reporting)
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC (Reporting)
SUSQUEHANNA SECURITIES, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/29/2020
4:30 PM
Achillion Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
3:17 PM
Achillion Pharmaceuticals (Issuer)
Zelenkofske Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
3:16 PM
Achillion Pharmaceuticals (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
3:16 PM
Achillion Pharmaceuticals (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2020
3:15 PM
Achillion Pharmaceuticals (Issuer)
Truitt Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
12:26 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:24 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:23 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:21 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:20 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:18 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:17 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:16 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:15 PM
Achillion Pharmaceuticals (Filer)
Form S-8 POS
01/28/2020
12:12 PM
Achillion Pharmaceuticals (Filer)
Form POS AM
01/28/2020
12:11 PM
Achillion Pharmaceuticals (Filer)
Form POS AM
01/28/2020
12:09 PM
Achillion Pharmaceuticals (Filer)
Form POS AM
01/28/2020
12:08 PM
Achillion Pharmaceuticals (Filer)
Form POS AM
01/28/2020
8:32 AM
Achillion Pharmaceuticals (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
01/28/2020
8:29 AM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2020
4:08 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
9:44 AM
Achillion Pharmaceuticals (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Form SC 13G
01/16/2020
2:07 PM
Achillion Pharmaceuticals (Subject)
ARP AMERICAS LP (Filed by)
Form SC 13G
01/16/2020
7:00 AM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
4:33 PM
Achillion Pharmaceuticals (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
4:24 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
11/21/2019
4:14 PM
Achillion Pharmaceuticals (Filer)
Form DEFM14A
11/20/2019
4:01 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
11/14/2019
5:47 PM
Achillion Pharmaceuticals (Issuer)
FISHERMAN JASON S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
5:46 PM
Achillion Pharmaceuticals (Issuer)
Scheer David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:17 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
11/07/2019
3:06 PM
Achillion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
4:06 PM
Achillion Pharmaceuticals (Filer)
Form PREM14A
11/01/2019
3:22 PM
Achillion Pharmaceuticals (Issuer)
Di Donato Brian (Reporting)
Form 3/A
10/18/2019
4:13 PM
Achillion Pharmaceuticals (Issuer)
Truitt Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:09 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
10/16/2019
3:54 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
10/16/2019
7:53 AM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
7:51 AM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
09/17/2019
3:05 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:03 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
3:01 PM
Achillion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/17/2019
8:00 AM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:04 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:03 PM
Achillion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/15/2019
3:18 PM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
04/15/2019
3:14 PM
Achillion Pharmaceuticals (Filer)
Form DEF 14A
04/01/2019
3:10 PM
Achillion Pharmaceuticals (Filer)
Form PRE 14A
03/07/2019
3:06 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
3:03 PM
Achillion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
8:17 AM
Achillion Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/11/2019
5:25 PM
Achillion Pharmaceuticals (Issuer)
Di Donato Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
5:23 PM
Achillion Pharmaceuticals (Issuer)
Di Donato Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2019
3:09 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
10:13 AM
Achillion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2019
6:13 AM
Achillion Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G
02/04/2019
9:09 AM
Achillion Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/25/2019
3:55 PM
Achillion Pharmaceuticals (Issuer)
Verwiel Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:55 PM
Achillion Pharmaceuticals (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:54 PM
Achillion Pharmaceuticals (Issuer)
Scheer David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:53 PM
Achillion Pharmaceuticals (Issuer)
KISHBAUCH MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:52 PM
Achillion Pharmaceuticals (Issuer)
Graves Kurt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:52 PM
Achillion Pharmaceuticals (Issuer)
FISHERMAN JASON S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:51 PM
Achillion Pharmaceuticals (Issuer)
Zelenkofske Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:50 PM
Achillion Pharmaceuticals (Issuer)
Truitt Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:49 PM
Achillion Pharmaceuticals (Issuer)
MANNING MARTHA E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:49 PM
Achillion Pharmaceuticals (Issuer)
Lantz Keri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:48 PM
Achillion Pharmaceuticals (Issuer)
Gibney Anthony S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:47 PM
Achillion Pharmaceuticals (Issuer)
Firuta Paul E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
3:30 PM
Achillion Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
4:35 PM
Achillion Pharmaceuticals (Issuer)
Lantz Keri (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2018
3:22 PM
Achillion Pharmaceuticals (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:04 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
3:03 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2018
3:07 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:06 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:03 PM
Achillion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/12/2018
4:57 PM
Achillion Pharmaceuticals (Issuer)
Firuta Paul E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
4:56 PM
Achillion Pharmaceuticals (Issuer)
Firuta Paul E (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2018
6:00 AM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2018
5:25 PM
Achillion Pharmaceuticals (Issuer)
Zelenkofske Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
5:23 PM
Achillion Pharmaceuticals (Issuer)
Zelenkofske Steven (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2018
4:34 PM
Achillion Pharmaceuticals (Issuer)
Gibney Anthony S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
4:33 PM
Achillion Pharmaceuticals (Issuer)
Gibney Anthony S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2018
3:46 PM
Achillion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2018
3:16 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
3:11 PM
Achillion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/08/2018
3:15 PM
Achillion Pharmaceuticals (Issuer)
FISHERMAN JASON S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
3:20 PM
Achillion Pharmaceuticals (Issuer)
VITULLO NICOLE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2018
3:05 PM
Achillion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2018
3:59 PM
Achillion Pharmaceuticals (Issuer)
Truitt Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2018
5:44 AM
Achillion Pharmaceuticals (Filer)
Form DEFA14A
This page was last updated on 4/8/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel